ACTIVATED CHARCOAL CAPSULES 250 MG — DIN 02504723
CHARCOAL ACTIVATED : 250 MG · NATURAL FACTORS NUTRITIONAL PRODUCTS LTD. · CAPSULE · wholesale supply in Canada
Health Canada status: MARKETED
What is ACTIVATED CHARCOAL CAPSULES?
ACTIVATED CHARCOAL CAPSULES 250 MG contains CHARCOAL ACTIVATED : 250 MG. It is listed in the Health Canada Drug Product Database under DIN 02504723, held by NATURAL FACTORS NUTRITIONAL PRODUCTS LTD., supplied as CAPSULE for ORAL administration. Health Canada currently lists it as marketed, status dated 31-Mar-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Is there a generic Medicinal Charcoal in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
21 holders have a Canadian DIN containing Medicinal Charcoal, across 29 DINs, of which 10 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| OMEGA LABORATORIES LIMITED | 4 | 3 | CHARAC-25, CHARAC-50, CHARACTOL-25, CHARACTOL-50 | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 2 | 2 | ACTIVATED CHARCOAL, WAMPOLE ACTIVATED CHARCOAL | Sourceable in Canada |
| LABORATOIRE LEO DESILETS M.H. INC | 2 | 1 | ACTIVATED CHARCOAL, ACTIVATED CHARCOAL POWDER | Sourceable in Canada |
| BIOCLINIC NATURALS INC. | 1 | 1 | ACTIVATED CHARCOAL CAPSULES | Sourceable in Canada |
| DSE HEALTHCARE SOLUTIONS LLC | 1 | 1 | CHARCO CAPS | Sourceable in Canada |
| EXZELL PHARMA INC | 1 | 1 | ACTIVATED CHARCOAL 260MG | Sourceable in Canada |
| NATURAL FACTORS NUTRITIONAL PRODUCTS LTD. | 1 | 1 | ACTIVATED CHARCOAL CAPSULES | Sourceable in Canada |
| PHARMASCIENCE INC | 3 | 0 | CHARCODOTE TFS SUS 200MG/ML, CHARCODOTE-AQUEOUS SUS 200MG/ML | No marketed DIN |
| FRANK W. KERR CHEMICAL COMPANY | 2 | 0 | INSTA CHAR ADULT 50GM/250ML, INSTA CHAR PEDIATRIC 15GM/120ML | No marketed DIN |
| ARKOPHARMA CANADA INC. | 1 | 0 | CHARCOAL | No marketed DIN |
| SOURCE OF LIFE PRODUCTS, DIVISION OF CHEMIMEX ENT | 1 | 0 | PREMIUM ACTIVATED CHARCOAL USP | No marketed DIN |
| VIVA PHARMACEUTICAL INC. | 1 | 0 | NORICOL | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 250 MG |
|---|---|
| Dosage form | CAPSULE |
| Route | ORAL |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Medicinal Charcoal |
|---|---|
| ATC code | A07BA01 |
| AHFS class | 56:04.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02504723 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2504723 |
| Brand name | ACTIVATED CHARCOAL CAPSULES |
| Generic / active ingredient | CHARCOAL ACTIVATED : 250 MG |
| Market authorization holder | NATURAL FACTORS NUTRITIONAL PRODUCTS LTD. |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A07BA01 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A07BA |
| Current status | MARKETED |
| Status date | 31-Mar-2021 |
| Original market date | 2021-03-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
10 of 29 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACTIVATED CHARCOAL | 225 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED | 02420694 |
| ACTIVATED CHARCOAL | 225 MG | CAPSULE | LABORATOIRE LEO DESILETS M.H. INC | MARKETED | 02236563 |
| ACTIVATED CHARCOAL 260MG | 260 MG | CAPSULE | EXZELL PHARMA INC | MARKETED | 00789674 |
| ACTIVATED CHARCOAL CAPSULES | 250 MG | CAPSULE | BIOCLINIC NATURALS INC. | MARKETED | 02537680 |
| CHARAC-25 | 222 MG | SUSPENSION | OMEGA LABORATORIES LIMITED | MARKETED | 02056429 |
| CHARAC-50 | 50 G / 225 ML | SUSPENSION | OMEGA LABORATORIES LIMITED | MARKETED | 00637955 |
| CHARACTOL-50 | 50 G / 250 ML | SUSPENSION | OMEGA LABORATORIES LIMITED | MARKETED | 00649236 |
| CHARCO CAPS | 260 MG | CAPSULE | DSE HEALTHCARE SOLUTIONS LLC | MARKETED | 02423715 |
| WAMPOLE ACTIVATED CHARCOAL | 225 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED | 02395517 |
| ACTIVATED CHARCOAL CAP 280MG | 280 MG | CAPSULE | NUTRITION PROFESSIONALS INC. | CANCELLED POST MARKET | 00643890 |
2 · Same class — other molecules in ATC A07BA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Medicinal Charcoal | ACTIVATED CHARCOAL · ACTIVATED CHARCOAL 260MG · ACTIVATED CHARCOAL CAP 280MG · ACTIVATED CHARCOAL CAPSULES · +20 more | 29 | 10 | Yes |
| Medicinal Charcoal, Combinations | CARBOSYLANE · CHAR-FLO WITH SORBITOL - SUS · FLAT-EEZE | 3 | 0 | Not in Canada |
| Charcoal Preparations | JAMP-ACTIVATED CHARCOAL · JAMP-ACTIVATED CHARCOAL PLUS | 2 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC A07B
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| A07BB | Bismuth Preparations | 55 | 12 |
| A07BC | Attapulgite · Attapulgite, Combinations · Combinations · Kaolin, Combinations · Pectin, Combinations | 20 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.